Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on European Global Times.
Press releases published on March 25, 2025
Cogent Biosciences Announces Multiple Poster Presentations at 2025 American Association for Cancer Research (AACR) Annual Meeting
GlobeNewswire
·
March 25, 2025
WALTHAM, Mass. and BOULDER, Colo., March 25, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced four preclinical poster …
Evaxion to present new phase 2 data for AI-designed personalized cancer vaccine EVX-01 at AACR Annual Meeting
GlobeNewswire
·
March 25, 2025
New biomarker and immune data from the ongoing phase 2 trial with EVX-01 will be presented at the American Association for Cancer Research (AACR) Annual Meeting These data will further add to the already strong clinical data package for EVX-01 The trial …
Zymeworks to Present Preclinical Data on T cell Engager and Antibody-Drug Conjugate Platforms in Six Posters at AACR Annual Meeting
GlobeNewswire
·
March 25, 2025
Novel trispecific T cell engager, ZW209, demonstrates potent preclinical efficacy against DLL3-expressing tumors and an encouraging safety profile New antibody-drug conjugate (ADC) candidate, ZW327, exhibits anti-tumor activity and a favorable …
Nouscom to Present Final Results from Successful Phase Ib/II Trial of NOUS-209 in People Living with Lynch Syndrome, Demonstrating Powerful Potential to Intercept Cancer in its Earliest Stages of Development
GlobeNewswire
·
March 25, 2025
Lynch Syndrome (LS) is a common hereditary condition that significantly increases the risk of developing cancer, especially colorectal and endometrial cancers NOUS-209 is an off-the-shelf immunotherapy designed to harness the power of the immune system to …
Affimed Announces Acceptance of AFM24 Abstract on Dose Optimization for Presentation at American Association for Cancer Research Annual Meeting
GlobeNewswire
·
March 25, 2025
MANNHEIM, Germany, March 25, 2025 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced an abstract on AFM24 dose optimization using …
T-knife Therapeutics Announces Five Presentations at American Association for Cancer Research (AACR) Annual Meeting
GlobeNewswire
·
March 25, 2025
Multiple presentations demonstrate that T-knife’s proprietary next-generation technologies address important challenges with current cell therapy constructs, including boosting T cell fitness and persistence within an immunosuppressive tumor …
Tango Therapeutics to Highlight Preclinical Data on Precision Oncology Pipeline with Five Posters at the American Association for Cancer Research (AACR) Annual Meeting 2025
GlobeNewswire
·
March 25, 2025
BOSTON, March 25, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that five abstracts have …
Tempest Announces Amezalpat Poster Presentation at the 2025 American Association for Cancer Research (AACR) Annual Meeting
GlobeNewswire
·
March 25, 2025
BRISBANE, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-classi targeted and immune-mediated therapeutics to fight cancer, today announced that an abstract …
Quanta Therapeutics Announces Late-Breaking Presentation of QTX3544, an Oral G12V-Preferring Multi-KRAS Inhibitor, at AACR Annual Meeting 2025
GlobeNewswire
·
March 25, 2025
SOUTH SAN FRANCISCO, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Quanta Therapeutics, a privately-held clinical-stage biopharmaceutical company leading the development of innovative, oral therapeutics for RAS-driven cancers, today announced it will give a …
Pyxis Oncology to Present New Preclinical Data Supporting Development of First-In-Concept ADC Targeting EDB+FN in Tumor Microenvironment at AACR 2025
GlobeNewswire
·
March 25, 2025
Expression data from patient-derived xenograft (PDX) mouse models exposed to micvotabart pelidotin (MICVO) indicate gene signatures associated with efficacy, deepening understanding of MOA and potential patient response Combination of a mouse analog of …
Nobiesse Introduces Men's Skincare with the Methylene Blue Morning Routine Kit
EIN Presswire
·
March 25, 2025
A premium skincare solution featuring methylene blue to enhance men’s skin resilience, hydration, and daily protection. NEW YORK, NY, UNITED STATES, March 25, 2025 /EINPresswire.com/ -- Nobiesse, a leader in luxury, non-toxic skincare, introduces an …
RSU Research Week Opening Session highlights the interaction between medicine, technology, and behavioural science
EIN Presswire
·
March 25, 2025
RSU Research Week 2025 opened on 24 March with an ambitious plenary session focusing on the role of research, technology, and the human factor in healthcare. RIGA, LATVIA, March 25, 2025 /EINPresswire.com/ -- RSU Research Week 2025 opened on 24 March …
Dan Pitulia Appointed as Group CEO of the Atlas Antibodies Group
EIN Presswire
·
March 25, 2025
The Board of Atlas Antibodies Group is pleased to announce the appointment of Dan Pitulia as the new Group Chief Executive Officer (CEO). STOCKHOLM, SWEDEN, March 25, 2025 /EINPresswire.com/ -- The Board of Atlas Antibodies Group is pleased to announce …
Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
GlobeNewswire
·
March 25, 2025
Soquelitinib Atopic Dermatitis Phase 1 Clinical Trial Data From Cohorts 1-3 anticipated to be Presented in May Initial Results From First Two Cohorts Supports Safety and Efficacy with Oral Agent and Novel Mechanism of Action Registration Phase 3 Clinical …
HSI Partners with KEY ESG to Offer Advanced ESG Capabilities to Customers across Europe and North America
EIN Presswire
·
March 25, 2025
HSI and KEY ESG have partnered to combine the advanced ESG functionalities of KEY ESG with the industry-leading, configurable EHS capabilities from HSI. FRISCO, TX, UNITED STATES, March 25, 2025 /EINPresswire.com/ -- HSI, a global leader in EHSQ and ESG …
Crete, Greece Named a 2025 Hotspot for New Vacation Home Developments
EIN Presswire
·
March 25, 2025
A wave of new developments and rising demand make Crete one of the most sought-after locations in Greece for vacation home buyers in 2025. RETHYMNO, GREECE, March 25, 2025 /EINPresswire.com/ -- Crete: A Hot Spot for New Vacation Home Developments The …
ALE launches Private 5G solution powered by Celona to expand IoT connectivity
EIN Presswire
·
March 25, 2025
New solution expands high quality connectivity in complex enterprise environments, large outdoor areas with seamless integration with ALE networking portfolio COLOMBES, FRANCE AND CAMPBELL, CA, UNITED STATES, March 25, 2025 /EINPresswire.com/ -- Alcatel …
Alcatel-Lucent Enterprise startet Private 5G-Lösung, ‚powered by Celona‘, für bessere IoT-Verbindungen
EIN Presswire
·
March 25, 2025
KORNWESTHEIM, DEUTSCHLAND UND CAMPBELL, CA, UNITED STATES, March 25, 2025 /EINPresswire.com/ -- Alcatel-Lucent Enterprise, führender europäischer Anbieter von sicheren Netzwerk- und Kommunikationslösungen zur Steigerung der betrieblichen Effizienz und …
ALE lance une solution de 5G privée basée sur la technologie Celona pour étendre la connectivité IoT
EIN Presswire
·
March 25, 2025
COLOMBES, FRANCE ET CAMPBELL, CA, UNITED STATES, March 25, 2025 /EINPresswire.com/ -- Alcatel-Lucent Enterprise, l’un des principaux fournisseurs de solutions de réseaux et de communication d’entreprise sécurisées, annonce le lancement d’une solution …
Rakovina Therapeutics Unveils Preclinical Data at the AACR - World’s Premier Cancer Research Forum
GlobeNewswire
·
March 25, 2025
VANCOUVER, British Columbia, March 25, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered drug discovery, today …